Alvotech

IPO

Better Access Better Lives

Public · Reykjavik, Iceland · Founded 2013

Headquarters
Reykjavik
Employees
501–1000
Founded
2013
Business Model
B2B
Type
Public

About

Alvotech develops and manufactures high-quality, cost-competitive biosimilars to broaden the availability of biologic medicines to patients around the world. The company believes that if there is a proven biologic medicine, it should be accessible to all patients in need. That commitment to the promise of biosimilars is foundational to Alvotech's approach, culture, and purpose of creating a healthier world through affordable biologics.

Summary

Alvotech is a Biotech company based in Reykjavik, Iceland, founded in 2013. Investors include Oaktree Capital Management, Oaktree Acquisition Corp. II and CVC Capital Partners.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

SPAC MergerSPAC MergerDec 2021
$450.0M

Sign up to see all 5 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alvotech on Indexed.vc
<a href="https://indexed.vc/companies/alvotech"><img src="https://indexed.vc/api/badge/company/alvotech" alt="Alvotech on Indexed.vc" width="260" height="76" /></a>